Baseline characteristics of the validation cohort comprising 113 patients with primary high grade non-muscle invasive bladder cancer.

Association Between Number of Endoscopic Resections and Utilization of Bacillus Calmette-Guérin Therapy for Patients With High-Grade, Non–Muscle-Invasive Bladder Cancer

Lenis, Andrew T
Donin, Nicholas M
Litwin, Mark S
Saigal, Christopher S
Lai, Julie
Hanley, Jan M
Konety, Badrinath R
Chamie, Karim
Project, Urologic Diseases in America

February 2017

BackgroundBacillus Calmette-Guérin (BCG) is the reference standard treatment for patients with high-...

Assessment of the oncological outcomes of three different bacillus Calmette–Guérin strains in patients with high-grade T1 non-muscle-invasive bladder cancer

Nowak L.
Krajewski W.
Moschini M.
Chorbinska J.
Poletajew S.
Tukiendorf A.
Muilwijk T.
Joniau S.
Tafuri A.
Antonelli A.
Orlando R.
Di Trapani E.
Alvarez-Maestro M.
Simone G.
Zamboni S.
Simeone C.
Marconi M. C.
Mastroianni R.
Piszczek R.
Xylinas E.
Zdrojowy R.

January 2021

Objective: : To determine whether there are significant differences in oncological outcomes between ...

Characteristics of 108 bladder cancer patients treated with cisplatin-based adjuvant chemotherapy.

Xin Zhang (35492)
Yanli Zhang (309699)
Xinfeng Liu (122953)
Aiju Fang (829347)
Peilong Li (755143)
Zewu Li (535621)
Tong Liu (107783)
Yongmei Yang (331969)
Lutao Du (332082)
Chuanxin Wang (332087)

November 2015

Characteristics of 108 bladder cancer patients treated with cisplatin-based adjuvant chemotherapy...

Baseline characteristics and the number of transurethral procedures during 2 and 5 years of follow-up for the cohort of non-muscle invasive bladder cancer (NMIBC) patients and their matched comparison cohort.

Lars Holmberg (73013)
Oskar Hagberg (5069237)
Christel Häggström (276145)
Truls Gårdmark (10099132)
Viveka Ströck (10099141)
Firas Aljabery (5594660)
Staffan Jahnson (10099135)
Abolfazl Hosseini (1370439)
Tomas Jerlström (10046416)
Amir Sherif (5474768)
Karin Söderkvist (11189729)
Anders Ullén (5997569)
Mats Enlund (13851132)
Fredrik Liedberg (39980)
Per-Uno Malmström (573918)

September 2022

Baseline characteristics and the number of transurethral procedures during 2 and 5 years of follow-u...

Baseline characteristics of primary non-muscle invasive bladder cancer patients.

Won Tae Kim (358508)
Seok Joong Yun (137708)
Cheol Park (358509)
Isaac Yi Kim (358510)
Sung-Kwon Moon (137717)
Tae Gyun Kwon (358511)
Yung Hyun Choi (132605)
Wun-Jae Kim (81624)

February 2013

Baseline characteristics of primary non-muscle invasive bladder cancer patients.</p

Baseline Characteristics of Primary Bladder Cancer Patients.

Se-Jung Lee (137703)
Eo-Jin Lee (137704)
Seon-Kyu Kim (23912)
Pildu Jeong (137705)
Young-Hwa Cho (137706)
Seok Joong Yun (137708)
Sangtae Kim (19293)
Gi-Young Kim (137710)
Yung Hyun Choi (132605)
Eun-Jong Cha (137713)
Wun-Jae Kim (81624)
Sung-Kwon Moon (137717)

September 2012

Abbreviations: NMIBC, non-muscle invasive bladder cancer; MIBC, muscle invasive bladder cancer.</...

Clinicopathological criteria predictive of recurrence following bacillus Calmette-Guérin therapy Initiation in non-muscle-invasive bladder cancer: Retrospective cohort study

Plasek, Joseph
Weissert, John
Downs, Tracy
Richards, Kyle
Ravvaz, Kourosh

June 2021

BACKGROUND: Bacillus Calmette-Guérin (BCG) is currently the most clinically effective intravesical t...

Clinicopathological Criteria Predictive of Recurrence Following Bacillus Calmette-Guérin Therapy Initiation in Non–Muscle-Invasive Bladder Cancer: Retrospective Cohort Study

Joseph Plasek
John Weissert
Tracy Downs
Kyle Richards
Kourosh Ravvaz

June 2021

BackgroundBacillus Calmette-Guérin (BCG) is currently the most clinically effective intravesical tre...

Baseline clinicopathological characteristics (n = 184).

Minna M. Boström (773544)
Heikki Irjala (456636)
Tuomas Mirtti (155123)
Pekka Taimen (773545)
Tommi Kauko (773546)
Annika Ålgars (579696)
Sirpa Jalkanen (101938)
Peter J. Boström (470005)

July 2015

1 TUR-BT; Transurethral resection of bladder tumor2 RC; Radical cyst...

T1 Substaging of Nonmuscle Invasive Bladder Cancer is Associated with bacillus Calmette-Guérin Failure and Improves Patient Stratification at Diagnosis

de Jong, Christiaan
Hoedemaeker, RF
Kvikstad, V
Mensink, JTM (Jolien)
de Jong, Joep
Boeve, ER
van der Schoot, DKE
Zwarthoff, Ellen
Boormans, Joost
Zuiverloon, Tahlita

March 2021

PURPOSE: Currently, markers are lacking that can identify patients with high risk nonmuscle invasive...

Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guerin (BCG): results of an international individual patient data survey (IPDS)

Witjes, J.A.
Palou, J.
Soloway, M.
Lamm, D.
Kamat, A.M.
Brausi, M.
Persad, R.
Buckley, R.
Colombel, M.
Bohle, A.

January 2013

OBJECTIVES: To examine the management of intermediate- and high-risk non-muscle-invasive bladder can...

Difference in recurrence frequencies of non-muscle-invasive-bladder tumors depending on optimal usage of intravesical immunotherapy of bacillus Calmette-Guérin

Milošević Radovan
Milović Novak
Aleksić Predrag
Lazić Miodrag
Cerović Snežana
Bančević Vladimir
Košević Branko
Marić Predrag
Spasić Aleksandar
Simić Dejan
Kovačević Božidar

January 2015

Background/Aim. The therapy with intravesical instillation of bacillus Calmette-Guérin (BCG) afte...

Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor

Ferro M.
Di Lorenzo G.
Vartolomei M. D.
Bruzzese D.
Cantiello F.
Lucarelli G.
Musi G.
Di Stasi S.
Hurle R.
Guazzoni G.
Busetto G. M.
Gabriele A.
Del Giudice F.
Damiano R.
Perri F.
Perdona S.
Verze P.
Borghesi M.
Schiavina R.
Almeida G. L.
Bove P.
Lima E.
Autorino R.
Crisan N.
Farhan A. R. A.
Battaglia M.
Russo G. I.
Ieluzzi V.
Morgia G.
De Placido P.
Terracciano D.
Cimmino A.
Scafuri L.
Mirone V.
De Cobelli O.
Shariat S.
Sonpavde G.
Buonerba C.

January 2020

Background: Basophils, eosinophils and monocytes may be involved in BCG-induced immune responses and...

Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor

M. Ferro
G. Di Lorenzo
M.D. Vartolomei
D. Bruzzese
F. Cantiello
G. Lucarelli
G. Musi
S. Di Stasi
R. Hurle
G. Guazzoni
G.M. Busetto
A. Gabriele
F. Del Giudice
R. Damiano
F. Perri
S. Perdona
P. Verze
M. Borghesi
R. Schiavina
G.L. Almeida
P. Bove
E. Lima
R. Autorino
N. Crisan
A.R.A. Farhan
M. Battaglia
G.I. Russo
V. Ieluzzi
G. Morgia
P. De Placido
D. Terracciano
A. Cimmino
L. Scafuri
V. Mirone
O. De Cobelli
S. Shariat
G. Sonpavde
C. Buonerba

January 2019

Background: Basophils, eosinophils and monocytes may be involved in BCG-induced immune responses and...

Risk factor assessment in high-risk, bacillus calmette–guérin-treated, non-muscle-invasive bladder cancer

Holz, Serge
Albisinni, Simone
Gilsoul, Jacques
Pirson, Michel
Duthie, Veronique
Quackels, Thierry
Vanden Bossche, Marc
Roumeguere, Thierry

September 2017

Objective: To assess the risk factors associated with recurrence, progression and survival in high-r...

Association Between Number of Endoscopic Resections and Utilization of Bacillus Calmette-Guérin Therapy for Patients With High-Grade, Non–Muscle-Invasive Bladder Cancer

Lenis, Andrew T
Donin, Nicholas M
Litwin, Mark S
Saigal, Christopher S
Lai, Julie
Hanley, Jan M
Konety, Badrinath R
Chamie, Karim
Project, Urologic Diseases in America

February 2017

BackgroundBacillus Calmette-Guérin (BCG) is the reference standard treatment for patients with high-...

Assessment of the oncological outcomes of three different bacillus Calmette–Guérin strains in patients with high-grade T1 non-muscle-invasive bladder cancer

Nowak L.
Krajewski W.
Moschini M.
Chorbinska J.
Poletajew S.
Tukiendorf A.
Muilwijk T.
Joniau S.
Tafuri A.
Antonelli A.
Orlando R.
Di Trapani E.
Alvarez-Maestro M.
Simone G.
Zamboni S.
Simeone C.
Marconi M. C.
Mastroianni R.
Piszczek R.
Xylinas E.
Zdrojowy R.

January 2021

Objective: : To determine whether there are significant differences in oncological outcomes between ...

Characteristics of 108 bladder cancer patients treated with cisplatin-based adjuvant chemotherapy.

Xin Zhang (35492)
Yanli Zhang (309699)
Xinfeng Liu (122953)
Aiju Fang (829347)
Peilong Li (755143)
Zewu Li (535621)
Tong Liu (107783)
Yongmei Yang (331969)
Lutao Du (332082)
Chuanxin Wang (332087)

November 2015

Characteristics of 108 bladder cancer patients treated with cisplatin-based adjuvant chemotherapy...

Baseline characteristics and the number of transurethral procedures during 2 and 5 years of follow-up for the cohort of non-muscle invasive bladder cancer (NMIBC) patients and their matched comparison cohort.

Lars Holmberg (73013)
Oskar Hagberg (5069237)
Christel Häggström (276145)
Truls Gårdmark (10099132)
Viveka Ströck (10099141)
Firas Aljabery (5594660)
Staffan Jahnson (10099135)
Abolfazl Hosseini (1370439)
Tomas Jerlström (10046416)
Amir Sherif (5474768)
Karin Söderkvist (11189729)
Anders Ullén (5997569)
Mats Enlund (13851132)
Fredrik Liedberg (39980)
Per-Uno Malmström (573918)

September 2022

Baseline characteristics and the number of transurethral procedures during 2 and 5 years of follow-u...

Baseline characteristics of primary non-muscle invasive bladder cancer patients.

Won Tae Kim (358508)
Seok Joong Yun (137708)
Cheol Park (358509)
Isaac Yi Kim (358510)
Sung-Kwon Moon (137717)
Tae Gyun Kwon (358511)
Yung Hyun Choi (132605)
Wun-Jae Kim (81624)

February 2013

Baseline characteristics of primary non-muscle invasive bladder cancer patients.</p

Baseline Characteristics of Primary Bladder Cancer Patients.

Se-Jung Lee (137703)
Eo-Jin Lee (137704)
Seon-Kyu Kim (23912)
Pildu Jeong (137705)
Young-Hwa Cho (137706)
Seok Joong Yun (137708)
Sangtae Kim (19293)
Gi-Young Kim (137710)
Yung Hyun Choi (132605)
Eun-Jong Cha (137713)
Wun-Jae Kim (81624)
Sung-Kwon Moon (137717)

September 2012

Abbreviations: NMIBC, non-muscle invasive bladder cancer; MIBC, muscle invasive bladder cancer.</...

Clinicopathological criteria predictive of recurrence following bacillus Calmette-Guérin therapy Initiation in non-muscle-invasive bladder cancer: Retrospective cohort study

Plasek, Joseph
Weissert, John
Downs, Tracy
Richards, Kyle
Ravvaz, Kourosh

June 2021

BACKGROUND: Bacillus Calmette-Guérin (BCG) is currently the most clinically effective intravesical t...

Clinicopathological Criteria Predictive of Recurrence Following Bacillus Calmette-Guérin Therapy Initiation in Non–Muscle-Invasive Bladder Cancer: Retrospective Cohort Study

Joseph Plasek
John Weissert
Tracy Downs
Kyle Richards
Kourosh Ravvaz

June 2021

BackgroundBacillus Calmette-Guérin (BCG) is currently the most clinically effective intravesical tre...

Baseline clinicopathological characteristics (n = 184).

Minna M. Boström (773544)
Heikki Irjala (456636)
Tuomas Mirtti (155123)
Pekka Taimen (773545)
Tommi Kauko (773546)
Annika Ålgars (579696)
Sirpa Jalkanen (101938)
Peter J. Boström (470005)

July 2015

1 TUR-BT; Transurethral resection of bladder tumor2 RC; Radical cyst...

T1 Substaging of Nonmuscle Invasive Bladder Cancer is Associated with bacillus Calmette-Guérin Failure and Improves Patient Stratification at Diagnosis

de Jong, Christiaan
Hoedemaeker, RF
Kvikstad, V
Mensink, JTM (Jolien)
de Jong, Joep
Boeve, ER
van der Schoot, DKE
Zwarthoff, Ellen
Boormans, Joost
Zuiverloon, Tahlita

March 2021

PURPOSE: Currently, markers are lacking that can identify patients with high risk nonmuscle invasive...

Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guerin (BCG): results of an international individual patient data survey (IPDS)

Witjes, J.A.
Palou, J.
Soloway, M.
Lamm, D.
Kamat, A.M.
Brausi, M.
Persad, R.
Buckley, R.
Colombel, M.
Bohle, A.

January 2013

OBJECTIVES: To examine the management of intermediate- and high-risk non-muscle-invasive bladder can...

Difference in recurrence frequencies of non-muscle-invasive-bladder tumors depending on optimal usage of intravesical immunotherapy of bacillus Calmette-Guérin

Milošević Radovan
Milović Novak
Aleksić Predrag
Lazić Miodrag
Cerović Snežana
Bančević Vladimir
Košević Branko
Marić Predrag
Spasić Aleksandar
Simić Dejan
Kovačević Božidar

January 2015

Background/Aim. The therapy with intravesical instillation of bacillus Calmette-Guérin (BCG) afte...

Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor

Ferro M.
Di Lorenzo G.
Vartolomei M. D.
Bruzzese D.
Cantiello F.
Lucarelli G.
Musi G.
Di Stasi S.
Hurle R.
Guazzoni G.
Busetto G. M.
Gabriele A.
Del Giudice F.
Damiano R.
Perri F.
Perdona S.
Verze P.
Borghesi M.
Schiavina R.
Almeida G. L.
Bove P.
Lima E.
Autorino R.
Crisan N.
Farhan A. R. A.
Battaglia M.
Russo G. I.
Ieluzzi V.
Morgia G.
De Placido P.
Terracciano D.
Cimmino A.
Scafuri L.
Mirone V.
De Cobelli O.
Shariat S.
Sonpavde G.
Buonerba C.

January 2020

Background: Basophils, eosinophils and monocytes may be involved in BCG-induced immune responses and...

Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor

M. Ferro
G. Di Lorenzo
M.D. Vartolomei
D. Bruzzese
F. Cantiello
G. Lucarelli
G. Musi
S. Di Stasi
R. Hurle
G. Guazzoni
G.M. Busetto
A. Gabriele
F. Del Giudice
R. Damiano
F. Perri
S. Perdona
P. Verze
M. Borghesi
R. Schiavina
G.L. Almeida
P. Bove
E. Lima
R. Autorino
N. Crisan
A.R.A. Farhan
M. Battaglia
G.I. Russo
V. Ieluzzi
G. Morgia
P. De Placido
D. Terracciano
A. Cimmino
L. Scafuri
V. Mirone
O. De Cobelli
S. Shariat
G. Sonpavde
C. Buonerba

January 2019

Background: Basophils, eosinophils and monocytes may be involved in BCG-induced immune responses and...

Risk factor assessment in high-risk, bacillus calmette–guérin-treated, non-muscle-invasive bladder cancer

Holz, Serge
Albisinni, Simone
Gilsoul, Jacques
Pirson, Michel
Duthie, Veronique
Quackels, Thierry
Vanden Bossche, Marc
Roumeguere, Thierry

September 2017

Objective: To assess the risk factors associated with recurrence, progression and survival in high-r...

Association Between Number of Endoscopic Resections and Utilization of Bacillus Calmette-Guérin Therapy for Patients With High-Grade, Non–Muscle-Invasive Bladder Cancer

Lenis, Andrew T
Donin, Nicholas M
Litwin, Mark S
Saigal, Christopher S
Lai, Julie
Hanley, Jan M
Konety, Badrinath R
Chamie, Karim
Project, Urologic Diseases in America

February 2017

BackgroundBacillus Calmette-Guérin (BCG) is the reference standard treatment for patients with high-...

Assessment of the oncological outcomes of three different bacillus Calmette–Guérin strains in patients with high-grade T1 non-muscle-invasive bladder cancer

Nowak L.
Krajewski W.
Moschini M.
Chorbinska J.
Poletajew S.
Tukiendorf A.
Muilwijk T.
Joniau S.
Tafuri A.
Antonelli A.
Orlando R.
Di Trapani E.
Alvarez-Maestro M.
Simone G.
Zamboni S.
Simeone C.
Marconi M. C.
Mastroianni R.
Piszczek R.
Xylinas E.
Zdrojowy R.

January 2021

Objective: : To determine whether there are significant differences in oncological outcomes between ...

Characteristics of 108 bladder cancer patients treated with cisplatin-based adjuvant chemotherapy.

Xin Zhang (35492)
Yanli Zhang (309699)
Xinfeng Liu (122953)
Aiju Fang (829347)
Peilong Li (755143)
Zewu Li (535621)
Tong Liu (107783)
Yongmei Yang (331969)
Lutao Du (332082)
Chuanxin Wang (332087)

November 2015

Characteristics of 108 bladder cancer patients treated with cisplatin-based adjuvant chemotherapy...

Baseline characteristics of the validation cohort comprising 113 patients with primary high grade non-muscle invasive bladder cancer.

Abstract

Extracted data

Baseline characteristics of the validation cohort comprising 113 patients with primary high grade non-muscle invasive bladder cancer.

Abstract

Extracted data

Related items

Related items